Probleme bei der Darstellung von ARIVA.DE?

  • Laden unsere Charts bei Ihnen nicht?
  • Wird unser Forum bei Ihnen nicht korrekt dargestellt?

Sie nutzen einen Adblocker, der hierfür verantwortlich ist. Hierauf hat ARIVA.DE leider keinen Einfluss. Bitte heben Sie die Blockierung von ARIVA.DE in Ihrem Adblocker auf.

Probleme bei der Darstellung von ARIVA.DE?

Top-Thema

14:48 Uhr
Aktien New York Ausblick: Dow auf Rekordkurs - Fed und Berichts­saison im Fokus

SHIRE PLC - Director/PDMR Shareholding

Freitag, 17.02.2017 13:05 von

PR Newswire

Director/PDMR Shareholding

February 17, 2017 – Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”)

Notification of transactions by person discharging managerial responsibilities

1. Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”)
a) Name Kim Stratton
2. Reason for the notification
a) Position / status Head of International Commercial – PDMR
b) Initial notification / amendment Amendment to prior notification to include the automatic disposal of Ordinary Shares, as omitted from the initial notification due to a transcription error, related to the automatic exercise of an option as detailed in the initial notification.
3. Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Shire plc Ordinary Shares of 5 pence each (“Ordinary Shares”)
Identification code ISIN: JE00B2QKY057
b) Nature of the transaction Automatic exercise of option over notional Ordinary Shares granted under the Shire Global Employee Stock Purchase Plan on November 1, 2015, and consequent receipt of Ordinary Shares.
c) Price(s) and volume(s) Price(s) Volume(s)
£40.70 244
d) Aggregated information N/A (single transaction)
e) Date of the transaction October 31, 2016
f) Place of the transaction N/A
5. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Shire plc Ordinary Shares of 5 pence each (“Ordinary Shares”)
 
Identification code ISIN: JE00B2QKY057
b) Nature of the transaction Automatic disposal of Ordinary Shares related to the automatic option exercise referenced in section 4. above. The proceeds of this disposal were used to satisfy personal tax liabilities arising from the option exercise.
c) Price(s) and volume(s) Price(s) Volume(s)
£46.07 9
d) Aggregated information N/A (single transaction)
e) Date of the transaction October 31, 2016
f) Place of the transaction London Stock Exchange (XLON)

Oliver Strawbridge

Senior Assistant Company Secretary

For further information please contact:

Investor Relations
Ian Karp ikarp@shire.com +1 781 482 9018
Robert Coates rcoates@shire.com +44 1256 894874
Media
Lisa Adler lisa.adler@shire.com +1 617 588 8607
Debbi Ford debbi.ford@shire.com  +1 617 949 9083

NOTES TO EDITORS

About Shire

Shire is the leading global biotechnology company focused on serving people with rare diseases. We strive to develop best-in-class products, many of which are available in more than 100 countries, across core therapeutic areas including Hematology, Immunology, Neuroscience, Ophthalmics, Lysosomal Storage Disorders, Gastrointestinal / Internal Medicine / Endocrine and Hereditary Angioedema; and a growing franchise in Oncology.

Our employees come to work every day with a shared mission: to develop and deliver breakthrough therapies for the hundreds of millions of people in the world affected by rare diseases and other high-need conditions, and who lack effective therapies to live their lives to the fullest.

www.shire.com